跳至主要内容
临床试验/CTRI/2021/12/038469
CTRI/2021/12/038469尚未招募未知

Open labelled, randomized controlled trial of All allogenic hematopoietic stem cell transplantation (HSCT) with standard graft versus host disease (GVHD) prophylaxis with or without sitagliptin.

Dr Sachin Suresh Jadhav0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方